As your body responds, we adapt your plan, so progress continues steadily
Out Semaglutide Medical Weight Loss Program is designed to provide you with the tool and support you need to achieve your weight loss goals
In May, the company, which had been growing over 50% in revenue year over year, began offering compounded GLP-1sa type of injectable weight loss drug for people with obesity
Evidence from previous studies show that weight loss can significantly reduce the risk of obesity-related complications and chronic diseases
Zepbound (Tirzepatide) Zepbound, a novel medication that targets both GLP-1 and GIP hormones, offers enhanced weight loss effectiveness
GLP-1 provides systemic metabolic benefits: Reduced Visceral Fat: GLP-1 preferentially mobilizes harmful visceral adiposity (fat around organs), which drives inflammation and cardiometabolic disease